Deal, United Kingdom

Christopher Peter Wayman

USPTO Granted Patents = 4 

Average Co-Inventor Count = 4.0

ph-index = 3

Forward Citations = 72(Granted Patents)


Location History:

  • Sandwich, GB (2004)
  • Kent, GB (2005)
  • County of Kent, GB (2006)
  • Deal, GB (2008)

Company Filing History:


Years Active: 2004-2008

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Christopher Peter Wayman: Innovator in Sexual Dysfunction Treatments

Introduction

Christopher Peter Wayman is a notable inventor based in Deal, GB. He has made significant contributions to the field of medical treatments, particularly focusing on sexual dysfunction. With a total of 4 patents to his name, Wayman has been instrumental in developing innovative solutions for this important health issue.

Latest Patents

Wayman's latest patents include a method of treatment for sexual dysfunction, specifically the use of an alpha-2-delta ligand, or a pharmaceutically acceptable derivative thereof, for the manufacture of a medicament aimed at treating premature ejaculation. Additionally, he has developed compounds for the treatment of sexual dysfunction, which describe polynucleotide and polypeptide sequences. These sequences are particularly useful in the prophylaxis and treatment of male erectile dysfunction (MED) and female sexual dysfunction (FSD), with a focus on female sexual arousal disorder (FSAD).

Career Highlights

Christopher Peter Wayman is currently employed at Pfizer Corporation, a leading global pharmaceutical company. His work at Pfizer has allowed him to collaborate with other experts in the field and contribute to groundbreaking research and development in sexual health.

Collaborations

Wayman has worked alongside notable colleagues such as Ian Dennis Harrow and Peter Stacey. Their combined expertise has fostered an environment of innovation and advancement in the treatments for sexual dysfunction.

Conclusion

Christopher Peter Wayman stands out as a key figure in the development of treatments for sexual dysfunction. His innovative patents and collaborations at Pfizer Corporation highlight his commitment to improving health outcomes in this area.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…